Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $369,140 | 28 | 89.6% |
| Travel and Lodging | $40,707 | 25 | 9.9% |
| Food and Beverage | $1,982 | 31 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $408,082 | 75 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,980 | 2 | $0 (2018) |
| Sumitomo Pharma America, Inc. | $250.02 | 2 | $0 (2023) |
| Novocure Inc. | $159.56 | 1 | $0 (2023) |
| Horizon Pharma plc | $124.50 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $111.61 | 1 | $0 (2018) |
| Lilly USA, LLC | $95.59 | 1 | $0 (2023) |
| PFIZER INC. | $26.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,400 | 1 | GlaxoSmithKline, LLC. ($23,400) |
| 2023 | $11,751 | 8 | GlaxoSmithKline, LLC. ($11,246) |
| 2022 | $137,345 | 8 | GlaxoSmithKline, LLC. ($137,345) |
| 2020 | $4,171 | 1 | GlaxoSmithKline, LLC. ($4,171) |
| 2019 | $37,612 | 22 | GlaxoSmithKline, LLC. ($37,612) |
| 2018 | $153,976 | 21 | GlaxoSmithKline, LLC. ($152,214) |
| 2017 | $43,575 | 23 | GlaxoSmithKline, LLC. ($42,095) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $23,400.00 | General |
| 10/03/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $159.56 | General |
| Category: Oncology | ||||||
| 09/06/2023 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $95.59 | General |
| 07/18/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: HORMONE THERAPY | ||||||
| 07/18/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: HORMONE THERAPY | ||||||
| 07/03/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $9,961.28 | General |
| 07/03/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $330.00 | General |
| 06/30/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $812.50 | General |
| 06/30/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $142.40 | General |
| 11/25/2022 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $2,948.51 | General |
| 11/25/2022 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $2,323.77 | General |
| 08/11/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $45,450.00 | General |
| 08/10/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $55,951.93 | General |
| 02/17/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $10,800.00 | General |
| 02/17/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 02/16/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $12,203.27 | General |
| 02/16/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,067.75 | General |
| 05/20/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,170.99 | General |
| 08/27/2019 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $32,265.00 | General |
| 07/02/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $199.98 | General |
| 07/02/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $53.36 | General |
| 07/02/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $30.68 | General |
| 07/02/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $22.11 | General |
| 07/02/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 07/02/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $13.04 | General |
About Dr. Steven Black, MD
Dr. Steven Black, MD is a Pediatrics healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467531509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Black, MD has received a total of $411,830 in payments from pharmaceutical and medical device companies, with $23,400 received in 2024. These payments were reported across 84 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($369,140).
Practice Information
- Specialty Pediatrics
- Location Oakland, CA
- Active Since 11/02/2006
- Last Updated 07/08/2007
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1467531509
Products in Payments
- FLUMIST (Drug) $2,980
- SHINGRIX (Biological) $675.00
- ORGOVYX (Drug) $250.02
- Optune (Device) $159.56
- KRYSTEXXA (Drug) $124.50
- ELIQUIS (Drug) $111.61
- PREVNAR - 13 (Biological) $26.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Oakland
Lela Bachrach, Md, MD
Pediatrics — Payments: $109,585
Nicola Klein, Md, MD
Pediatrics — Payments: $71,606
Keith Quirolo, M.d, M.D
Pediatrics — Payments: $12,456
Sam Lu, M.d, M.D
Pediatrics — Payments: $9,143
Dr. Dayna Long, M.d, M.D
Pediatrics — Payments: $7,401
Dr. Omoniyi Omotoso, M.d., M.p.h., Faap, M.D., M.P.H., FAAP
Pediatrics — Payments: $5,864